EE396 Healthcare Costs Among Real-World Patients with Recurrent or Metastatic Cervical Cancer (r/mCC) Receiving Second-Line (2L) Treatment
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.644
https://www.valueinhealthjournal.com/article/S1098-3015(22)00845-2/fulltext
Section Title :
Section Order :
10575
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00845-2&doi=10.1016/j.jval.2022.04.644